NIMH Grant Awarded to Dr. Serena Spudich
new R01 from the National Institute of Mental Health (NIMH) has been awarded to Principal Investigator Dr. Serena Spudich. The R01MH125396 grant, “PET imaging of synaptic density combined with neuroimmunologic measures to reveal mechanism of HIV Neuropathogenesis during ART,” began on 9/15/20 and was awarded for 5 years (to 7/31/25).
Dr. Emily Gilmore & ELECTRO-BOOST Team Awarded $3.25M NINDS Grant
Principal Investigators Dr. Emily Gilmore, MD (Yale), Dr. Kan Ding, MD (UTSW), and Dr. Eric Rosenthal, MD (Massachusetts General Hospital) have received a $3.25 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) for their project entitled: "ELECTRO-BOOST: Electroencephalography for cerebral trauma recovery and oxygenation."
$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
Parkinson’s Disease Study Identifies Possible New Treatment Target
Treatments for Parkinson’s disease have most recently focused on increasing dopamine, a chemical messenger in the brain that affects reward-based behaviors and motivation, as well as movement. A new study by Yale researchers challenges long-held assumptions about dopamine’s sole role in this disorder.
Imaging Offers Potential Way To Predict MS
Naila Makhani, MD, MPH, and her colleagues are using a five-year grant from the National Institutes of Health to launch a prospective study of children will identify those with a higher risk of developing MS and the biomarkers that can aid in early diagnosis.
MS risk in children spotted with MRI brain scans
By the time multiple sclerosis (MS) is diagnosed in children, it may be difficult to prevent the disabilities and relapses that come with the disease. In a new Yale School of Medicine study, researchers examined MRI brain scans to identify children at high risk of developing MS before symptoms appear, which may lead to earlier diagnosis and treatment.
Yale Medicine Muscular Dystrophy Program Designated a Certified Duchenne Center
Yale Medicine’s Muscular Dystrophy Program has been named a Certified Duchenne Care Center by Parent Project Muscular Dystrophy (PPMD), a nonprofit organization dedicated to ending Duchenne muscular dystrophy (Duchenne).
Brain impairments in premature infants may begin in the womb
Even before they are born, premature babies may display alterations in the circuitry of their developing brains, according to a first-of-its kind research study by Yale School of Medicine researchers and their colleagues at the National Institutes of Health (NIH) and Wayne State University.
WHRY Launches Studies on Endometrial Cancer, Addiction to Opioids, and Stroke
While continuing to focus on the impacts of COVID-19, the center has enlarged its research portfolio to include new projects on the prevention of endometrial cancer in a growing cohort of women at high risk, non-opioid pain management following a cesarean section for women with opioid use disorder who are in recovery, and sex differences in stroke.
Neurology Committee for Diversity and Inclusion Elects Co-Chairs
The Department of Neurology has elected three Co-Chairs to lead its Committee for Diversity and Inclusion (CDI): Dr. Kunal Desai, MD (Faculty Co-Chair), Dr. LaShae Nicholson, PhD (Staff C-Chair), and Dr. Razaz Mageid, MD (Trainee Co-Chair).
Neurology Establishes Committee on Diversity and Inclusion
The Department of Neurology’s new Committee on Diversity and Inclusion convened for the first time on Friday, June 26, 2020. The committee’s purpose is to promote diversity within the department’s education, career development, and leadership initiatives.